Internal Medicine, Gastroenterology · Chicago, IL
NPI
1558302257
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1725 W Harrison St, Suite 207
Chicago, IL, 60612
Phone (312) 942-5861
Groups this clinician bills Medicare through
Medicare paid, 2024
$18K
196 services
Medicare patients, 2024
120
Average age 73
Drug cost, 2024
$6.1M
1,423 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ali Keshavarzian was code 99214 (office e&m - established), 52 times for 45 patients. In total Ali Keshavarzian billed 196 services in 17 codes, and Medicare paid $18K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 52 | 45 | $68.50 | $3,562 |
| 45380 Lower GI Endoscopy - Other | Facility | 36 | 36 | $144.39 | $5,198 |
| 99213 Office E&M - Established | Office | 21 | 21 | $72.15 | $1,515 |
| 99214 Office E&M - Established | Office | 19 | 17 | $90.97 | $1,728 |
| 99213 Office E&M - Established | Facility | 15 | 15 | $50.75 | $761 |
By year: 2022 $22K for 246 services; 2023 $19K for 206 services; 2024 $18K for 196 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ali Keshavarzian prescribed most often to Medicare patients was Stelara (Ustekinumab), with 126 prescriptions and refills. In total Ali Keshavarzian wrote 1,423 Medicare prescriptions that cost $6.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Stelara Ustekinumab | 126 | 155 | 16 | $3.6M |
| Motegrity Prucalopride Succinate | 84 | 118 | 14 | $67K |
| Pantoprazole Sodium Generic | 68 | 193 | 26 | $895 |
| Mesalamine Generic | 67 | 175 | 20 | $38K |
| Sodium Chloride 0.9 % Sodium Chloride | 62 | 67 | Under 11 | $456 |
| Humira(Cf) Pen Adalimumab | 58 | 65 | Under 11 | $619K |
| Colestipol Hcl Generic | 49 | 148 | 16 | $3,189 |
| Dicyclomine Hcl Generic | 48 | 101 | 15 | $1,604 |
| Linzess Linaclotide | 47 | 91 | Under 11 | $47K |
| Famotidine Generic | 44 | 120 | 16 | $689 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 44 | 44 | 39 | $2,903 |
| Azathioprine Generic | 34 | 101 | Under 11 | $902 |
| Rinvoq Upadacitinib | 33 | 33 | Under 11 | $221K |
| Sulfasalazine Generic | 30 | 68 | Under 11 | $1,109 |
| Omeprazole Generic | 26 | 56 | Under 11 | $271 |
Brand drugs: - claims; generic drugs: 712 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Ali Keshavarzian were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.